[The effect of plasmapheresis on hemostasis in lung cancer patients]

To correct hemostasis, 32 patients with lung carcinoma underwent plasmapheresis with exfusion of 50% the circulating plasma volume one day before surgery. Plasmapheresis was coupled with the conventional drug therapy. As compared with the control group patients (n-32) who did not receive plasmapheresis, the main group patients demonstrated that the use of the multimodality correcting therapy made all the components of hemostasis return to normal and minimized the rate of postoperative thromboembolic complications by 40.6% and the postoperative lethality by 18.7%.